KRT18 and COVID-19: K18-hACE2 mice are well recognized as a suitable model for studying upper respiratory tract pathogenesis in the context of SARS-CoV-2 [12,16,18], even though the model fails to simulate severe and lethal cases of COVID-19, including its neuroinvasive potential without full neurodissemination [12,21,51].